Open for Enrollment Soon
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.
SBT0000-01 - Clinical Trial
What is the Purpose of this Study?
Observational study.
What is the Condition Being Studied?
A person can join this study if they have already received at least one dose of a Treg treatment in an earlier study.
Who Can Participate in the Study?
Must have completed the parent study.
Age Group
Adults
What is Involved?
This study is a Phase 4 observational study. It takes place at several medical centers. The goal is to check the long-term safety of people who have already received a special treatment made by Sonoma Biotherapeutics. This treatment uses gene-modified Treg cells. The study watches how these people do over time after receiving the treatment in an earlier study.
Study Details
Full Title
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Principal Investigator
Tarannum Jaleel, MD
Dermatologist
Protocol Number
IRB:
PRO00119094
Phase
Phase IV
Enrollment Status
Open for Enrollment Soon